NCT05255926View on ClinicalTrials.gov

CXCR4-targeted PET/CT Imaging in Hematological Malignancies

NARecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
CXCR4PET/CTHematological Malignancy
Interventions
DRUG

68Ga-pentixafor

All participants undergo intravenous administration of 68Ga-pentixafor (1.85-3.71 MBq/kg body weight).

DEVICE

PET/CT

PET/CT imaging is performed 1 h after intravenous injection of 68Ga-pentixafor.

Trial Locations (1)

430071

RECRUITING

Zhongnan Hospital of Wuhan University, Wuhan

All Listed Sponsors
lead

Zhongnan Hospital

OTHER